Just how long will aptiom continue to be promoted?

Discussion in 'Sunovion' started by anonymous, Aug 17, 2023 at 6:01 PM.

Tags: Add Tags
  1. #1 anonymous, Aug 17, 2023 at 6:01 PM
    anonymous

    anonymous Guest

    Just how long will Aptiom continue to be promoted?
     
    Quote

  2. #2 anonymous, Aug 17, 2023 at 9:32 PM
    anonymous

    anonymous Guest

    The little engine that could.
     
    Quote
  3. #3 anonymous, Aug 19, 2023 at 4:19 PM
    anonymous

    anonymous Guest

    Until they decide to stop promoting it.
     
    Quote
  4. #4 anonymous, Aug 20, 2023 at 11:37 AM
    anonymous

    anonymous Guest

    Typical answer from a little twat like you.
     
    Quote
  5. #5 anonymous, Aug 22, 2023 at 8:23 PM
    anonymous

    anonymous Guest

    The NCE patent expires in 2026. Other MOU patents expire in 2028-2032. Patents already being challenged. Expect 2-3 years, unless Sunovion, oops, Sumitomo decides to jettison it early.
     
    Quote
  6. #6 anonymous, Aug 23, 2023 at 11:38 AM
    anonymous

    anonymous Guest

    Good chance it’s sold to another pharma company due to the current cash poor position we are in from nonstop miss management.
     
    Quote
  7. #7 anonymous, Aug 26, 2023 at 4:25 PM
    anonymous

    anonymous Guest

    This cookie cutter leadership team is stuck in the Latuda world and disconnected and clueless to the epilepsy world.
     
    Quote
  8. #8 anonymous, Aug 27, 2023 at 10:54 AM
    anonymous

    anonymous Guest

    Oh come on Aptiom is only a few trackers and spread sheets away from being a billion dollar product.
     
    Quote
  9. #9 anonymous, Aug 29, 2023 at 10:41 AM
    anonymous

    anonymous Guest

    This is right but wrong. Yes, there are patents but Sunovion settled on the 2025 patent with the generic manufacturers to get 4 more years from 2021.

    May 2025 will be the jail break.
     
    Quote
Reply to Thread